Acumen Hypotension Prediction Index – EV1000 Clinical Platform vs VX1+

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Acumen Hypotension Prediction Index – EV1000 Clinical Platform
by Edwards Lifesciences
VS
VX1+
by Volta Medical

AI Verdict

Tool A focuses on predicting and managing hypotension by monitoring hemodynamic stability across various critical care and surgical settings. In contrast, Tool B is specifically designed to assist electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for arrhythmias. While both utilize AI within cardiology and surgical domains, they address distinct clinical challenges and cater to different sub-specialties.

Choose Acumen Hypotension Prediction Index – EV1000 Clinical Platform if…

Choose Acumen Hypotension Prediction Index if your primary goal is to proactively prevent and manage intraoperative or critical care hypotension. This tool is ideal for anesthesiologists and critical care teams needing early warnings and insights into hemodynamic instability to optimize patient blood pressure before adverse events occur.

View Acumen Hypotension Prediction Index – EV1000 Clinical Platform →

Choose VX1+ if…

Choose VX1+ if you are an electrophysiologist performing cardiac ablation procedures for atrial fibrillation or tachycardia and require AI-powered real-time guidance. This software is best suited for assisting in the precise identification of abnormal electrograms to enhance the effectiveness of ablation strategies.

View VX1+ →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform VX1+
Deployment On-premise (integrated with EV1000 clinical platform and HemoSphere advanced monitoring platform) Software, compatible with most multipolar catheters and mapping technologies used in operating rooms or electrophysiology labs.
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

VX1+

Tool B explicitly highlights a 'simple user interface with color coding' and boasts compatibility with multiple existing EP recording and 3D mapping systems. This suggests a design focused on broad, intuitive integration into diverse clinical environments. Tool A, while integrated, is tied to a specific vendor's hardware platform, which could limit its plug-and-play usability for facilities not already using Edwards' ecosystem.

Clinical Value

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Tool A's ability to predict a common and serious complication like hypotension up to 15 minutes in advance allows for proactive intervention, potentially impacting a broader range of patients in critical care and surgical settings. While Tool B offers significant value in a specialized procedure, Tool A's preventative nature and wider applicability to a more prevalent clinical issue give it an edge in overall clinical impact.

Pricing & Value

Tie

Both tools lack public pricing information, making it impossible to assess their relative cost or value for money. While both offer significant clinical benefits that could lead to improved patient outcomes and potential cost savings, a direct comparison on this dimension is not feasible without transparent pricing details.

Enterprise Readiness

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

Backed by Edwards Lifesciences, a large and established global medical technology company, Tool A benefits from robust enterprise-level support, sales, and service infrastructure. Its explicit HIPAA compliance and integration within a major vendor's ecosystem demonstrate a higher degree of readiness for large-scale deployment and long-term maintenance compared to a newer startup.

Innovation

VX1+

Tool B's real-time, AI-powered identification of complex spatio-temporal dispersed electrograms during dynamic cardiac ablation procedures represents a highly specialized and cutting-edge application of AI. While Tool A's predictive capabilities for hypotension were innovative, Tool B addresses a more intricate, real-time diagnostic challenge in a highly specialized surgical context, pushing the boundaries of AI in a niche field.

Support & Docs

Acumen Hypotension Prediction Index – EV1000 Clinical Platform

As a product of Edwards Lifesciences, a large and established global medical technology company, Tool A benefits from a mature and extensive support infrastructure, comprehensive technical documentation, and dedicated field service teams. A startup like Volta Medical, while potentially offering good support, is unlikely to match the global reach and established resources of a major corporation.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Acumen Hypotension Prediction Index – EV1000 Clinical Platform VX1+
Name Acumen Hypotension Prediction Index u2013 EV1000 Clinical Platform VX1+
Company Edwards Lifesciences Volta Medical
Tagline Predicting and managing hypotension before it occurs. Transforming EP Data into AI Solutions
Description The Acumen Hypotension Prediction Index (HPI) software by Edwards Lifesciences uses machine learning to predict hypotensive events up to 15 minutes in advance, providing clinicians with insights into hemodynamic instability and potential causes to help reduce intraoperative hypotension. AI-powered software that assists electrophysiologists in real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia.
Primary Clinical Focus Prediction and management of hypotension Real-time identification of abnormal electrograms during cardiac ablation procedures for atrial fibrillation and atrial tachycardia
Specialties Anesthesiology, Critical Care, Emergency Medicine Cardiology
Key Features (partial list) HPI Parameter (0-100 likelihood score), Smart Alerts for trending hypotension, Predicts hypotension up to 15 minutes in advance Real-time manual or automatic annotation of 3D anatomical and electrical maps, Identification of spatio-temporal dispersed electrograms (DEs), AI-driven insights to assist electrophysiologists

Videos

Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform and VX1+.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Acumen HPI provides continuous hemodynamic monitoring and predicts hypotensive events up to 15 minutes in advance, allowing clinicians to proactively manage instability and potentially reduce intraoperative hypotension. It offers insights into preload, afterload, and contractility to guide interventions. VX1+ assists electrophysiologists in real-time by identifying abnormal electrograms during cardiac ablation procedures for atrial fibrillation and tachycardia. This real-time annotation aims to improve the precision and efficacy of ablation by guiding the physician to target specific areas.
Acumen HPI offers a predictive HPI Parameter (0-100 likelihood score) for hypotension and a 'Relationship View screen' that provides insights into the underlying hemodynamic causes (preload, afterload, contractility). This allows for targeted interventions before a hypotensive event fully manifests. VX1+ uses AI to identify spatio-temporal dispersed electrograms (DEs) and provides real-time manual or automatic annotations on 3D anatomical and electrical maps of the heart. This helps electrophysiologists pinpoint specific areas for ablation that might be difficult to identify with traditional methods.
While not explicitly detailed, Acumen HPI presents a 0-100 likelihood score and 'Smart Alerts' for trending hypotension, suggesting a relatively intuitive interpretation of immediate risks. The 'Relationship View screen' provides deeper insights that may require some initial understanding of hemodynamic parameters. VX1+ features a 'simple user interface with color coding for electrogram dispersion (blue, orange, red),' indicating a design focused on ease of interpretation. This suggests a potentially rapid learning curve for electrophysiologists already familiar with 3D mapping systems.
Acumen HPI is integrated with Edwards Lifesciences HemoSphere Advanced Monitoring Platform (and previously EV1000 Clinical Platform) via dedicated sensors (Acumen IQ cuff or sensor). This indicates a tight integration within the Edwards ecosystem. VX1+ is designed to integrate with existing EP recording and 3D mapping systems, specifically mentioning compatibility with systems like Boston Scientific LabSystem Pro, GE HealthCare MacLab CardioLab EP Recording System, and Abbott EnSite X 3D mapping system.
Acumen HPI generates continuous data related to hemodynamic status, HPI parameters, and smart alerts, which can be retrospectively viewed and analyzed using Acumen Analytics software for insights into the frequency, duration, and prevalence of intraoperative hypotension. VX1+ provides real-time manual or automatic annotation of electrograms and identifies spatio-temporal dispersed electrograms. This annotated data, along with cycle length estimations, would likely be captured within the integrated EP recording and 3D mapping systems, offering a detailed record of the procedure.
Multi-site rollout for Acumen HPI would primarily depend on the existing or planned deployment of the Edwards Lifesciences HemoSphere Advanced Monitoring Platform and the availability of dedicated Acumen IQ sensors across sites. Standardization would involve training on this integrated system. For VX1+, multi-site implementation would require ensuring compatibility with the specific existing EP recording and 3D mapping systems at each site. The 'simple user interface' could aid in standardizing training and adoption across different locations.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Acumen Hypotension Prediction Index – EV1000 Clinical Platform or VX1+

AI Tool Finder
AI-powered search. Results may not be comprehensive.